Stay current with the latest sickle cell research, regulatory updates, and guidelines.
To evaluate whether red blood cell (RBC)-bound ADP-ribosylation factor-like protein 13b (ARL13b), a cilia-associated protein, is associated with future vaso-occlusive crises (VOC) and disease severity in sickle cell disease (SCD),...
To evaluate the criterion validity of the Functional Status Pain Assessment (FSPA), a 10-item functional assessment tool, by examining its relationship with pain intensity and hospital length of stay (LOS)...
To evaluate whether intravenous (IV) diphenhydramine use is associated with new-onset acute chest syndrome (ACS) among adults hospitalized for vaso-occlusive episodes (VOE), while adjusting for inpatient opioid exposure.
To describe the outcomes of a sustained, collaborative, long-term multidisciplinary health provider andcommunity advisory group focused on improving sickle cell disease (SCD) care, education, and research.
To investigate cerebral microvascular injury in a humanized mouse model of sickle cell disease (SCD) and examine the relationship between cerebral microhemorrhages (CMHs) and mast cells.
To evaluate digital cognitive behavioral therapy (CBT) versus usual care for reducing pain intensity and pain interference among adolescents and young adults with sickle cell disease (SCD), and to compare...
To describe the use of kyphoplasty for management of vertebral compression fractures and chronic spinal pain in a patient with sickle cell disease (SCD)–associated osteonecrotic spinal pathology.
To evaluate the prevalence of psychosocial neglect and patterns of under-recognized psychosis among young adults with sickle cell disease (SCD) and to examine their impact on treatment, pain reduction, and...
To evaluate whether implementation of a standardized electronic medical record (EMR) admission order set could improve hospitalization outcomes for patients admitted with sickle cell pain crisis.
To investigate whether vaso-occlusive episodes (VOE) and other clinical factors influence variability in urine albumin-to-creatinine ratio (UACR) in patients with sickle cell disease (SCD).